Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of elagolix for moderate to severe endometriosis-associated pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd. | Conditions: Endometriosis | Phase 3 | Status: UNKNOWN